Detalhe da pesquisa
1.
The evolution of non-small cell lung cancer metastases in TRACERx.
Nature
; 616(7957): 534-542, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046095
2.
The evolution of lung cancer and impact of subclonal selection in TRACERx.
Nature
; 616(7957): 525-533, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046096
3.
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
N Engl J Med
; 386(21): 1973-1985, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403841
4.
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists.
Histopathology
; 84(3): 429-439, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957137
5.
An endogenous inhibitor of angiogenesis downregulated by hypoxia in human aortic valve stenosis promotes disease pathogenesis.
J Mol Cell Cardiol
; 174: 25-37, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36336008
6.
Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non-small-cell lung cancer.
Future Oncol
; 19(8): 549-557, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815433
7.
Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.
Pharmacol Rev
; 72(3): 639-667, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32554488
8.
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists.
Br J Cancer
; 125(9): 1210-1216, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34489586
9.
Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach.
Oncologist
; 26(2): e306-e315, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33145902
10.
Tracking the Evolution of Non-Small-Cell Lung Cancer.
N Engl J Med
; 376(22): 2109-2121, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28445112
11.
Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort.
Mod Pathol
; 33(5): 792-801, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740722
12.
Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity?
Future Oncol
; 15(12): 1363-1383, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30758227
13.
Whole Transcriptome Analysis of Pre-invasive and Invasive Early Squamous Lung Carcinoma in Archival Laser Microdissected Samples.
Respir Res
; 18(1): 12, 2017 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28073359
14.
Tracking genomic cancer evolution for precision medicine: the lung TRACERx study.
PLoS Biol
; 12(7): e1001906, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25003521
16.
Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group.
Thorax
; 71(2): 177-84, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26530085
17.
PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementation.
Histopathology
; 69(2): 177-86, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27196116
18.
Immune Checkpoint Blockade: A New Era for Non-Small Cell Lung Cancer.
Curr Oncol Rep
; 18(9): 59, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27484062
19.
BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas.
Histopathology
; 64(4): 547-56, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24266897
20.
Improving practice in PD-L1 testing of non-small cell lung cancer in the UK: current problems and potential solutions.
J Clin Pathol
; 77(2): 135-139, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36604178